InsiderTrades.com logo
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

EWI Insider Trading

Insider Ownership Percentage: 4.34%
Insider Buying (Last 12 Months): £19,600
Insider Selling (Last 12 Months): GBX 0

Edinburgh Worldwide Investment Trust Insider Trading History Chart

This chart shows the insider buying and selling history at Edinburgh Worldwide Investment Trust by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Edinburgh Worldwide Investment Trust Share Price & Price History

Current Price: GBX 139.60
Price Change: ▼ Price Decrease of -2.4 (-1.69%)
As of 04/25/2024 05:35 PM ET

This chart shows the closing price history over time for EWI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

Edinburgh Worldwide Investment Trust Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/3/2023Jonathan Simpson-DentInsiderBuy14,000GBX 140£19,600
3/10/2023Jonathan Simpson-DentInsiderBuy5,000GBX 158£7,900
1/24/2023Caroline RoxburghInsiderBuy8,324GBX 179£14,899.96
9/30/2022Helen JamesInsiderBuy11,872GBX 168£19,944.96
9/1/2022Jonathan Simpson-DentInsiderBuy9,000GBX 185£16,650
4/7/2022Jonathan Simpson-DentInsiderBuy10,000GBX 216£21,600
1/31/2022Jonathan Simpson-DentInsiderBuy4,500GBX 213£9,585
10/29/2021Mungo WilsonInsiderBuy30,000GBX 323£96,900
See Full Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

SEC Filings (Institutional Ownership Changes) for Edinburgh Worldwide Investment Trust (LON:EWI)

8.23% of Edinburgh Worldwide Investment Trust stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Edinburgh Worldwide Investment Trust logo
Edinburgh Worldwide Investment Trust plc is a closed-ended equity mutual fund launched and managed by Baillie Gifford & Co Ltd. The fund is co-managed by Baillie Gifford & Co. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies that are operating across diversified sectors. It primarily invests in growth stocks of small cap companies having market capitalization of less than $5 billion. The fund benchmarks the performance of its portfolio against the MSCI All Countries World Index. Edinburgh Worldwide Investment Trust plc was formed in 1998 and is domiciled in the United Kingdom.
Read More on Edinburgh Worldwide Investment Trust

Today's Range

Now: GBX 139.60
Low: 139.30
High: 141.40

50 Day Range

MA: GBX 145.52
Low: 137.80
High: 149.60

52 Week Range

Now: GBX 139.60
Low: 120.80
High: 157.80

Volume

854,642 shs

Average Volume

681,485 shs

Market Capitalization

£536.90 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.8

Who are the company insiders with the largest holdings of Edinburgh Worldwide Investment Trust?

Edinburgh Worldwide Investment Trust's top insider shareholders include:
  1. Caroline Roxburgh (Insider)
  2. Helen James (Insider)
  3. Jonathan Simpson-Dent (Insider)
Learn More about top insider investors at Edinburgh Worldwide Investment Trust.
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...